The in vivo xenograft adoptive transfer (AdT) model demonstrates that both VHP354 and QZC131 can broadly activate and redirect cytotoxic T cells toward tumor cells to induce human T cell-mediated cytotoxicity in vivo in an LYPD1- and dose-dependent manner. Here, LYPD1 is linked to neoplasm.